Business

Unexpected Growth Scenario Seen In Global Digital Therapeutics Market

By Kavita Sharma 18 Jan, 2022 536
Unexpected Growth Scenario seen in Global Digital Therapeutics Market

Global digital therapeutics market was valued at US$ 1658.3 million in 2020 and is expected to reach US$ 9,121.8 million by 2030 growing at an estimated CAGR of 21.1% over the forecast period. The research report titled Digital Therapeutics market has recently been added by Absolute Markets Insights to its massive database which offers a lucid understanding of various business aspects of the Digital Therapeutics market. The market report has been studied by means of primary and secondary research techniques. The report also covers the extensive data of historical records, existing scenarios, and future market growth prospects. Additionally, the report also offers SWOT analysis to discover market propellers and restraints of the businesses. The report also offers a holistic snapshot of the competitive landscape which helps to differentiate the competition at global and national level. In order to discover the risks and challenges faced by businesses, several types of business model have been examined. Graphical presentation techniques such as info graphics, chart, tables, and pictures are touched upon while curating this report. This helps to generate a strong footing for detailed analysis of recent trends and technological advancements in the Digital Therapeutics market. Furthermore, the case study provides region wise productivity in a concise manner.

Top Key Players includes in this report: Adherium, BigHealth, BLUE MESA HEALTH, CANARY HEALTH, Chrono Therapeutics Inc., Diabetes Digital Media Ltd, Digital Therapeutics, Inc., Dthera Sciences, Firstbeat, GINGER.IO, Glooko, Inc., Limbix , Livongo Health, MANGO HEALTH, Merck & Co., Inc., Noom, Inc., Novartis AG, Omada Health, Inc., Propeller Health, Proteus Digital Health, WellDoc, Inc. among others.

Browse the Full Information of this report: https://www.absolutemarketsinsights.com/reports/Digital-Therapeutics-Market-2019-2027-199

Growing need to control healthcare costs along with rising incidence of chronic diseases are factors that assist the global digital therapeutics market. Digital therapeutics is essentially delivering evidence-based therapeutic interventions to patients to manage, treat, or prevent a chronic disease or disorder. The basal insulin dose calculator for patients suffering from Type 2 diabetes is an ideal instance for digital therapeutics. 

In terms of revenue, the software segment accounted for more than 60% of the overall digital therapeutics market. The software-based tools help in managing the conditions of patients by modifying their behavioral patterns. The concept of more apps and fewer drugs can be an effective means to cure chronic diseases. For instance, the management of diabetes require regular interventions about glycemic control and adjusting insulin dose, thus offering patients a friendly self-tracking tool that organizes virtual visits with caregivers via communication interface. 

Global Digital Therapeutics Market

By Products

  • Software
  • Devices

By Application

  • Cardiovascular Diseases
  • Central Nervous System (CNS) Disease
  • Diabetes
  • Gastrointestinal Disorders (GID)
  • Mental Health
  • Neurology
  • Obesity
  • Ophthalmology
  • Respiratory Diseases
  • Smoking Cessation
  • Others

By Distribution Channel

  • Business to Business
  • Business to Customer

By End User

  • Patients
  • Healthcare Providers
  • Payers
  • Employers
  • Other (Fitness and Wellness Centers, Gym, Etc.)

By Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East and Africa
  • Latin America

Contact Us:
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com 
Phone: IN +917400242424, US +1-510-420-1213
Contact Name: Shreyas Tanna
Website: www.absolutemarketsinsights.com/